News

Astrocyte Pharmaceuticals Raises Over $1.3M in Seed Financing Round

Astrocyte Pharmaceuticals Inc., a CNS therapeutics startup, announced today that it has raised approximately $1.36M in a seed financing round. The company is developing novel small molecule drugs that limit neuronal damage in patients that have suffered a stroke, traumatic brain injury (TBI) or concussion. The seed financing round was led by Boston Harbor Angels, and joined by the University of Texas Horizon Fund, SideCar Angels and others. Read more >>
Read more...

Brian able to see wife for first time ever

Brian Casey thought he would never see properly again after losing his sight nearly 27 years ago. The former mechanic, who lives in Fleetwood, was left with virtually no vision after two fluke sports injuries occurred within exactly a year of each other. But thanks to a remarkable piece of technology, Brian has been able to see clearly and even managed to look upon his wife Beverly’s face for the first time ever. Brian, 51, enjoyed what he calls a “life changing”...
Read more...

Carbonite Promotes New Channel Chief With Plans To Integrate Double-Take, Expand Programs

Cloud-based data protection technology developer Carbonite has promoted a relatively new executive to head its channel program. Jon Whitlock, who joined Carbonite in December as VP of channel marketing, this week was elevated to VP of channel sales and marketing, replacing Jessica Couto, who has left the company. Read more >>
Read more...

Inside the small Norwood biotech that’s making investors swoon

The top-performing public biotech in Massachusetts over the past year is located in a nondescript brick building with no signage, located along a stretch of highway in Norwood that is better known for its car dealerships than drug developers. Investors in Corbus Pharmaceuticals don’t much seem to mind. The 3-year-old company, situated some 25 miles south of Cambridge and the bustling biotech hub of Kendall Square, has seen its stock price increase more than 400 percent since March 2016, putting it...
Read more...